Evolocumab attenuate pericoronary adipose tissue density via reduction of lipoprotein(a) in type 2 diabetes mellitus: a serial follow-up CCTA study

医学 Evolocumab公司 血管病学 内科学 2型糖尿病 脂肪组织 糖尿病 心脏病学 2型糖尿病 还原(数学) 脂蛋白 胆固醇 内分泌学 载脂蛋白A1 几何学 数学
作者
Meng-Meng Yu,Xin Zhao,Yinyin Chen,Xinwei Tao,Junbo Ge,Hang Jin,Meng-Su Zeng
出处
期刊:Cardiovascular Diabetology [BioMed Central]
卷期号:22 (1) 被引量:1
标识
DOI:10.1186/s12933-023-01857-w
摘要

Abstract Background Pericoronary adipose tissue (PCAT) density is a biomarker of vessel inflammation, which is supposed to be increased in patients with type 2 diabetes mellitus (T2DM). However, whether the coronary inflammation revealed by this novel index could be alleviated after evolocumab treatment in T2DM remains unknown. Methods From January 2020 to December 2022, consecutive T2DM patients with low-density lipoprotein cholesterol ≥ 70 mg/dL on maximally tolerated statin and taking evolocumab were prospectively included. In addition, patients with T2DM who were taking statin alone were recruited as control group. The eligible patients underwent baseline and follow-up coronary CT angiography with an interval of 48-week. To render patients with evolocumab as comparable to those controls, a propensity-score matching design was used to select the matched pairs with a 1:1 ratio. Obstructive lesion was defined as the extent of coronary artery stenosis ≥ 50%; the numbers inside the brackets were interquartile ranges. Results A total of 170 T2DM patients with stable chest pain were included [(mean age 64 ± 10.6 [range 40–85] years; 131 men). Among those patients, 85 were in evolocumab group and 85 were in control group. During follow-up, low-density lipoprotein cholesterol (LDL-C) level (2.02 [1.26, 2.78] vs. 3.34 [2.53, 4.14], p < 0.001), and lipoprotein(a) (12.1 [5.6, 21.8] vs. 18.9 [13.2, 27.2], p = 0.002) were reduced after evolocumab treatment. The prevalence of obstructive lesions and high-risk plaque features were significantly decreased ( p < 0.05 for all). Furthermore, the calcified plaque volume were significantly increased (188.3 [115.7, 361.0] vs. 129.3 [59.5, 238.3], p = 0.015), while the noncalcified plaque volume and necrotic volume were diminished (107.5 [40.6, 180.6] vs. 125.0 [65.3, 269.7], p = 0.038; 0 [0, 4.7] vs. 0 [0, 13.4], p < 0.001, respectively). In addition, PCAT density of right coronary artery was significantly attenuated in evolocumab group (− 85.0 [− 89.0, − 82.0] vs. − 79.0 [− 83.5, − 74.0], p < 0.001). The change in the calcified plaque volume inversely correlated with achieved LDL-C level (r = − 0.31, p < 0.001) and lipoprotein(a) level (r = − 0.33, p < 0.001). Both the changes of noncalcified plaque volume and necrotic volume were positively correlated with achieved LDL-C level and Lp(a) ( p < 0.001 for all). However, the change of PCAT RCA density only positively correlated with achieved lipoprotein(a) level (r = 0.51, p < 0.001). Causal mediation analysis revealed Lp(a) level mediated 69.8% ( p < 0.001) for the relationship between evolocumab and changes of PCAT RCA . Conclusions In patients with T2DM, evolocumab is an effective therapy to decrease noncalcified plaque volume necrotic volume, and increase calcified plaque volume. Furthermore, evolocumab could attenuate PCAT density, at least in part, via the reduction of lipoprotein(a).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
3秒前
4秒前
Ava应助坚定路人采纳,获得10
6秒前
8秒前
9秒前
潘善若发布了新的文献求助10
9秒前
戴岱发布了新的文献求助10
11秒前
12秒前
13秒前
momo发布了新的文献求助10
15秒前
大模型应助潘善若采纳,获得10
15秒前
16秒前
jolt发布了新的文献求助10
17秒前
18秒前
传奇3应助戴岱采纳,获得10
19秒前
nini完成签到,获得积分10
21秒前
zzzjh发布了新的文献求助10
21秒前
量子星尘发布了新的文献求助10
22秒前
22秒前
24秒前
25秒前
nini发布了新的文献求助10
28秒前
Lucas应助XAN采纳,获得10
29秒前
潘善若发布了新的文献求助10
29秒前
棠棠完成签到 ,获得积分10
29秒前
32秒前
yyer完成签到,获得积分10
32秒前
34秒前
FashionBoy应助潘善若采纳,获得10
35秒前
慕青应助忐忑的阑香采纳,获得10
35秒前
momo发布了新的文献求助10
36秒前
冰淇淋完成签到,获得积分10
36秒前
XylonYu完成签到,获得积分10
37秒前
39秒前
坚定路人发布了新的文献求助10
41秒前
张宁波完成签到,获得积分0
42秒前
sue完成签到,获得积分10
43秒前
44秒前
慕青应助害羞的山柏采纳,获得10
45秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989297
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253893
捐赠科研通 3270097
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809158